Innovation in Ireland →
Managing director, the Foundry Group
CEO and Founder, Techstars
Head of global research and development at Life Technologies
Chairman, CEO, & Founder, Alexandria Real Estate Equities
Founder, Gilt Groupe
Professor of Systems Biology, Columbia University
Co-Founder and CEO, Wetpaint
May 6, 2015 ·
May 21, 2015 ·
June 1, 2015 ·
Ascent Therapeutics, based in Cambridge, MA, is developing a new class of drugs to target cell surface receptors involved in many diseases.
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin and beyond.
© 2007-2015, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.